Tune in to the latest episode of the GOLD podcast which sees Isabel sit down for a chat with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.

In the episode, Wendy discusses her passion for developing life-saving cancer drugs with less toxic side effects. Learn about how far the industry has come, while being guided through the ways in which the sector could still evolve for the benefit of patients.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Going for gold in gynaecological cancers
• Mental health matters in pharma's approach to care
• Last week's podcast: What motivates and challenges GOLD's guests?